Iradimed (IRMD) Cash from Investing Activities (2013 - 2026)
Iradimed's (IRMD) quarterly Cash from Investing Activities came in at -$443000.0 in Q2 2026, up 84.31% year-over-year from -$240352.0 in Q2 2025, and up 5.54% quarter-over-quarter from -$469000.0 in Q1 2026.
Powered by 
Analysis
Iradimed (IRMD) Cash from Investing Activities (2013 - 2026) Analysis & Trends
Iradimed (IRMD) has reported Cash from Investing Activities for 14 consecutive years, with -$443000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Investing Activities rose 84.31% year-over-year to -$443000.0 in Q2 2026; TTM through Jun 2026 was -$2.6 million, a 81.23% increase from a year earlier, with the FY2025 full-year figure at -$8.4 million, up 4.49% from the prior year.
- Cash from Investing Activities was -$443000.0 for Q2 2026 at Iradimed, up from -$469000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $77561.0 in Q2 2022 and troughed at -$6.6 million in Q1 2023.
- A 5-year average of -$1.5 million and a median of -$517495.5 in 2022 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities sank 1443.94% in 2023 and surged 92.7% in 2024, its largest moves.
- Over 5 years, Cash from Investing Activities stood at -$471676.0 in 2022, then sank by 34.16% to -$632816.0 in 2023, then slumped by 383.07% to -$3.1 million in 2024, then jumped by 86.38% to -$416407.0 in 2025, then dropped by 6.39% to -$443000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$443000.0 (Q2 2026), -$469000.0 (Q1 2026), and -$416407.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Iradimed | 1.07 Bn | 1.01 Bn | 15.16 Mn | -443,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -443,000.00 |
| Mar 31, 2026 | -469,000.00 |
| Dec 31, 2025 | -416,407.00 |
| Sep 30, 2025 | -1.26 Mn |
| Jun 30, 2025 | -2.82 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -3.06 Mn |
| Sep 30, 2024 | -4.01 Mn |
| Jun 30, 2024 | -1.27 Mn |
| Mar 31, 2024 | -478,803.00 |
| Dec 31, 2023 | -632,816.00 |
| Sep 30, 2023 | -439,023.00 |
| Jun 30, 2023 | -378,314.00 |
| Mar 31, 2023 | -6.56 Mn |
| Dec 31, 2022 | -471,676.00 |
| Sep 30, 2022 | -556,188.00 |
| Jun 30, 2022 | 77,561.00 |
| Mar 31, 2022 | -424,694.00 |
| Dec 31, 2021 | 259,778.00 |
| Sep 30, 2021 | -220,584.00 |